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Abstract: Nanoparticles can be used as a smart drug delivery system, when they release
the drug only upon degradation by specific enzymes. A method to create such responsive
materials is the formation of hydrogel nanoparticles, which have enzymatically degradable
crosslinkers. Such hydrogel nanoparticles were prepared by ionotropic gelation sodium alginate
with lysine-rich peptide sequences—either α-poly-L-lysine (PLL) or the aggrecanase-labile sequence
KKKK-GRD-ARGSV↓NITEGE-DRG-KKKK. The nanoparticle suspensions obtained were analyzed
by means of dynamic light scattering and nanoparticle tracking analysis. Degradation experiments
carried out with the nanoparticles in suspension revealed enzyme-induced lability. Drugs present
in the polymer solution during the ionotropic gelation can be encapsulated in the nanoparticles.
Drug loading was investigated for interferon-β (IFN-β) as a model, using a bioluminescence
assay with MX2Luc2 cells. The encapsulation efficiency for IFN-β was found to be approximately
25%. The nanoparticles suspension can be used to spray-coat titanium alloys (Ti-6Al-4V) as a
common implant material. The coatings were proven by ellipsometry, reflection-absorption infrared
spectroscopy, and X-ray photoelectron spectroscopy. An enzyme-responsive decrease in layer
thickness is observed due to the degradation of the coatings. The Alg/peptide coatings were
cytocompatible for human gingival fibroblasts (HGFIB), which was investigated by CellTiterBlue
and lactate dehydrogenase (LDH) assay. However, HGFIBs showed poor adhesion and proliferation
on the Alg/peptide coatings, but these could be improved by modification of the alginate with a
RGD-peptide sequence. The smart drug release system presented can be further tailored to have the
right release kinetics and cell adhesion properties.
Keywords: smart drug delivery; ionotropic gelation; nanogel; enzymatic cleavage;
cyto-compatibility; cell adherence; alginate; X-ray photoelectron spectroscopy; reflection-absorption
infrared spectroscopy
1. Introduction
Stimuli-responsive release strategies are expected to have a major impact on the development
of innovative drug delivery systems (DDS) [1]. The application of nanomaterials as drug carriers
has been shown to increase drug stability, reduce drug resistance, and even enhance therapeutic
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efficacy [2]. Moreover, drug-loaded nanoparticles (NP) with controlled release mechanisms offer the
great advantage that a single dose can sustain therapeutically effective drug levels over a long period.
Stimuli-responsive controlled drug release systems have been published by several groups. Amongst
these are drug carriers responding to internal stimuli, such as pH, ionic strength, and biomolecules.
Drug delivery systems can be also responsive to external stimuli, like ultrasound, light, magnetic
fields, or chemical agents [3–11]. Herein, we report on the possibility of utilizing biomolecules like
enzymes to trigger a specific drug release. Enzymes are critically involved in many biological and
metabolic processes, representing a variable toolbox to work with. Thus, enzymes pose an attractive
opportunity to catalyze chemical reactions under mild conditions, like low temperature, moderate
pH, and buffered solutions [12–14]. Furthermore, their remarkable selectivity towards their substrates
paves the way for innovative drug delivery systems [14,15].
The fabrication of nanomaterials exhibiting certain biomolecule responsiveness has already
been studied. The most prominent strategy includes the preparation of enzyme labile carriers that
are stable in absence of a corresponding enzyme and will be degraded when it is present [13,15].
Preferentially, the considered enzymes are secreted as a result of a disease to immediately trigger the
drug release, which then helps to overcome the pathogenic situation. Such intelligent drug delivery
systems are preferentially prepared from a biopolymer scaffold that is degradable itself, or from a
polymer and a degradable linker. Baier et al. have fabricated polyhexanide-loaded hyaluronic acid
nanocapsules using the inverse miniemulsion technique [16]. These capsules are degraded when
the inflammation-related hyaluronidase is present and leads to a drug release. Radhakrishnan et
al. developed dual-responsive microparticles based on the arginine-rich protein protamine and the
biopolymer chondroitin sulfate. The degradation and subsequent drug release have been performed
in the presence of infection-relevant enzymes, either trypsin or hyaluronidase [17]. Similar approaches
have been pursued by the introduction of specific peptide sequences that serve as a crosslinker for the
polymer matrix. In this way, the corresponding cleavage site can be simply tailored through peptide
synthesis to adjust directly the release properties, depending on the enzyme. This strategy has been
used by Seliktar et al., who introduced a thiol-endcapped metalloproteinase labile peptide sequence
to crosslink polyethylene glycol hydrogels [18]. Fuchs et al. have fabricated nanoparticles based on
polystyrene–peptide–polystyrene triblock polymers. By incorporation of an enzymatically degradable
peptide middle block, they were able to demonstrate the release of a fluorescent dye upon addition of
trypsin and hepsin [19].
Our approach is based on the preparation of nanogels through ionotropic gelation of the
biopolymer sodium alginate with a specific peptide crosslinker, and subsequent coating of implants
with this nanogel dispersion. The biodegradable and biocompatible alginates, extracted from brown
algae, are extremely versatile biomaterials with manifold applications in the field of biomedicine [20].
The use of the biopolymer sodium alginate as a matrix for the encapsulation and delivery of
biomolecules like proteins, DNA, or cells has been intensively studied [21–23]. The biological activity
of guest molecules is widely preserved due to the relatively mild gelation in the presence of counter
ions and the avoidance of organic solvents [24]. Enzyme-labile alginate hydrogels can be prepared by
introducing specific peptide sequences as a complexation partner. Fonseca et al. transformed sodium
alginate into a three-dimensional cell culture microenvironment equipped with enzyme-labile peptide
sequences. The lability against matrix metalloproteinases (MMPs) helped to prepare degradable
alginate networks for tissue engineering [25].
Due to their negative charge in aqueous media alginates, they can be used to form nanoparticles
in combination with an appropriate multivalent cation (e.g., calcium ions) [26]. Here we studied the
particle formation properties of alginate with two lysine-rich and therefore cationic peptides, namely
α-poly-L-lysine (PLL) or an aggrecanase-labile sequence (KKKK-GRD-ARGSV↓NITEGE-DRG-KKKK)
equipped with an additional tripeptide spacer and four lysine residues on each side. The protease
aggrecanase belongs to the family of ADAM (a disintegrin and metalloprotease) proteins. It is mainly
secreted during the early stages of inflammations—for instance, in osteoarthritis—and leads to the
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degradation of cartilage [27,28]. The nanoparticles were formed through an ionotropic gelation
process based on electrostatic interactions, since this method is a promising tool for encapsulation of
proteins [29]. The particles were characterized with regard to particle size by means of dynamic light
scattering (DLS) and nanoparticle tracking analysis (NTA). The stability of the colloidal systems was
investigated by zeta potential measurements. The nanogel dispersions can be used to coat implant
surfaces, for example, by spray coating in order to obtain bioactive surfaces or antibacterial surfaces,
which can release growth factors [30] or antibacterial substances. As a model for an implant, we used
polished plates of a commonly used titanium alloy (Ti-6Al-4V). The characterization of the layers
has been performed by ellipsometry, reflection-absorption infrared spectroscopy (RAIRS), and X-ray
photoelectron spectroscopy (XPS). With regard to developing a DDS, we designed a biodegradable
system to include hydrophobic proteins, such as interferon-β (IFN-β), which possesses antiproliferative
and immune modulatory therapeutic effects [31].
2. Materials and Methods
2.1. Materials
Polyethyleneimine (PEI) was obtained from Sigma-Aldrich (St. Louis, MO, USA) and
diluted to 5% (v/v) with MilliQ water. Poly-L-lysine hydrochloride (PLL, molecular weight
1.6 kDa, equals 12–13 lysine units) was bought from Alamanda Polymers (Huntsville, AL, USA).
The aggrecanase-labile peptide sequence “KKKK-NITEGE↓ARGSV-KKKK-carboxyl” (NITEGE) was
prepared at the Helmholtz Centre for Infection Research (Braunschweig, Germany), according to
standard solid-phase peptide synthesis protocols. All solutions were filtered through 0.22 µm
Millex–GP (polyethersulfon; Sigma-Aldrich) filters before use. Glycosylated IFN-β was purchased
from PBL Interferon Source (Piscataway, NJ, USA) and was treated according to the manufacturer’s
instructions. Trypsin, thermolysin, and alginate-lyase were all obtained from Sigma-Aldrich and used
as received.
Titanium alloy substrates (1 mm thick, Goodfellow, Hamburg, Germany) were cut into 1 × 1 cm2
squares and treated as described below. Acetone, methanol, ethanol, and dichloromethane were
distilled before use.
2.2. Alginate Purification
Sodium alginate (Alg, average molecular weight 80 kDa) was purchased from Sigma-Aldrich.
The purification was performed according to the protocol published by Prokop and Wang with slight
changes [32]. Briefly, sodium alginate was dissolved in deionized water (1 g alginate/15 mL water)
and was dialyzed (10 kDa MW cutoff) for three days, with continuous water exchange. Afterwards,
the solution was stirred at room temperature with 0.5 g activated charcoal per gram sodium alginate,
filtered through a Buchner funnel, lyophilized, and stored at −20 ◦C until use.
2.3. Ionotropic Gelation
The Alg/PLL and Alg/NITEGE-nanoparticles were prepared according to the following general
procedure. Purified sodium alginate was dissolved in MilliQ water to obtain a final concentration of
1 mg/mL. After complete dissolution, a 1 mg/mL PLL or NITEGE solution was flush mixed with the
alginate solution. Nanoparticles are formed spontaneously by electrostatic interaction between anionic
alginate molecules and cationic peptides. Particle characterization with regard to particle size and zeta
potential was performed right after preparation.
For encapsulation of IFN-β, ionic gelation was carried out with only slight modifications to the
abovementioned protocol. An IFN-β stock solution was diluted to a concentration of 5000 relative
light units (RLU) per mL. Subsequently, a defined volume of sodium alginate solution (1 mg/mL),
was pipetted into a flask before the required volume of IFN-β solution was added. Nanoparticles
then spontaneously formed upon addition of PLL or NITEGE solutions (1 mg/mL), respectively.
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The encapsulation efficacy was determined to be around 25%. The nanoparticle suspensions obtained
were characterized for each batch by dynamic light scattering.
2.4. Particle Size and Zeta Potential
Particle size and zeta potential measurements were carried out using a Zetasizer Nano ZS
from Malvern Instruments (Malvern, UK). Disposable sizing cuvettes (DTS0012) were used for
size measurements, and clear disposable zeta cells (DTS1060C) for zeta potential measurements.
All measurements were performed at 20 ◦C except the particle degradation experiments, which were
conducted at 37 ◦C. Malvern Zetasizer Software Version 7.03 was used for data evaluation.
2.5. Nanoparticle Degradation
The degradation of the Alg/peptide nanoparticles was carried out through the addition of
trypsin, thermolysin, and alginate-lyase to the nanoparticle dispersion. Briefly, 990 µL Alg/peptide
nanoparticle suspensions (1 mg/mL) were filled in a Zetasizer sizing cell and maintained at 37 ◦C.
Different enzyme solutions (trypsin, thermolysin, alginate-lyase) were added in order to obtain final
concentrations of 2.5 µg/mL. The degradation process was then monitored via consecutive size
measurements using the Zetasizer Nano ZS.
2.6. Nanoparticle Tracking Analysis
Alg/peptide suspensions were prepared according to the standard procedure and subjected to
NTA using Nanosight NS300 equipment and NTA 3.1 software (both from Malvern Instruments) for
the data analysis to obtain the diameter of particles. The suspensions were diluted 1:10 in MilliQ water
prior to the measurement. The images were captured using a sCMOS camera at camera level 15, slider
shutter set at 1206, slider gain at 366 and frames per second at 25. 1498 frames were captured and
analyzed at a detection threshold set to 8, and max jump distance set to 11.2 pixels.
2.7. Bioluminescence Measurement in Solution
Mx2Luc2 cells were seeded in 24-well cell culture plates with 5 × 104 cells per well and incubated
overnight at 37 ◦C. The next day, the Dulbecco’s modified Eagle’s medium (DMEM) was removed
before IFN-β in medium (concentration series) or the supernatant of the centrifuged Alg/NITEGE/
IFN-β (encapsulation efficiency measurement) was added. The treated cells were incubated overnight
at 37 ◦C before the supernatant was removed. Each well was washed with phosphate buffered saline
(PBS) and treated with 125 µL reporter lysis buffer (RLB). The 24-well plates were stored in a refrigerator
at 80 ◦C for at least 30 min. In a tube, 20 µL of each well was pipetted into 100 µL of luciferin solution
and subsequently measured with Lumat LB 9507 by Berthold Technologies (Bad Wildbad, Germany).
2.8. Bioluminescence Measurement from Coated Titanium Substrates
A 20 µL solution of IFN-β-loaded Alg/peptide nanoparticles was coated onto PEI-modified
titanium samples. After rinsing with water, the titanium samples were incubated in different
media, including DMEM, DMEM with fetal calf serum (FCS), or PBS. After different periods of
time, the supernatants were analyzed by the bioluminescent assay as described before.
2.9. Surface Coating
The modification of Ti-6Al-4V substrate surfaces with Alg/peptide nanoparticles was carried
out following a general procedure: The substrates were grinded, polished, and cleaned through
ultrasonification in distilled dichloromethane, acetone, methanol, and MilliQ water. The washed
samples were plasma cleaned and subsequently used for surface coating. Firstly, the substrates were
immersed for 1 min in an aqueous 5% (v/v) PEI solution before rinsing in water for 15 s. The PEI-coated
substrates were then spray-coated manually with an airbrush Aztek A470 from Testors (Vernon Hills,
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IL, USA) for 3 min, depositing approximately 20 µL of the Alg/peptide nanoparticle formulation.
Afterwards, the substrates were rinsed in MilliQ water and dried in a stream of nitrogen.
2.10. Ellipsometry
Layer thicknesses were determined using a Multiskop from Optrel (Sinzing, Germany) in the
ellipsometry mode. Uncoated titanium plates served as a reference for the corresponding coated
samples. Data were collected in the x,y-mode at 70◦ as mean value of 16 data points in total. Evaluation
of the data was carried out using Elli Version 3.2 from Optrel.
2.11. Reflection-Absorption Infrared Spectroscopy
Reflection-absorption infrared spectroscopy spectra on coated titanium plates were recorded
using a Bruker Equinox 55 FTIR spectrometer (Bruker Optik GmbH, Ettlingen, Germany) equipped
with a Bruker A518 RAIRS module reflecting the infrared beam at an angle of 80◦ to the MCT detector.
Background measurements were carried out with uncoated substrates in the range of 4000–400 cm−1,
at 10 KHz and 32 scans before each coated sample was analyzed (4000–400 cm−1, 10 KHz and 64 Scans).
Instrument control and initial data processing were performed using Opus software (Version 4.0.24)
from Bruker (Billerica, MA, USA).
2.12. X-ray Photoelectron Spectroscopy
X-ray photoelectron spectroscopy measurements were carried out using the X-ray photoelectron
spectrometer Axis Supra from Kratos Analytical (Manchester, UK), equipped with a monochromatized
Al Kα X-ray source. Survey scans were acquired using a pass energy of 160 eV. High-resolution spectra
(C1s, O1s, N1s, and Ti2p) were obtained using a pass energy of 20 eV. An area of 700 µm x 300 µm of
each sample was analyzed with a power of 300 W, applying a charge neutralizator for 2 min.
2.13. Cytocompatibilty of the Nanoparticle Suspension
Cytocompatibility was tested with human gingival fibroblasts (HGFIB, Cat No.: 121 0412),
which were purchased from Provitro GmbH (Berlin, Germany). The cells were cultured in DMEM
(FG0435, Biochrom AG, Berlin, Germany) supplemented with 10% FCS (P270521, PAN-Biotech GmbH,
Aidenbach, Germany), 100 U/mL penicillin, and 100 µg/mL streptomycin (A2212; Biochrom AG,
Berlin, Germany). The cells were incubated at 37 ◦C in a 5% CO2, 95% humidified air atmosphere.
The cytocompatibility of the nanoparticle suspensions was studied by determining the cellular
membrane damage and metabolic activity of human gingival fibroblasts. Human gingival fibroblasts
were seeded in 96-well cell culture plates at a density of 1.5 × 104 cells/mL and precultured for
24 h. The alginate nanoparticle suspensions were diluted in DMEM supplemented with 5% FCS,
100 U/mL penicillin, and 100 µg/mL streptomycin. The nanoparticles were diluted to different
concentrations of 12.5, 25, 50, 100, and 200 µg/mL to represent the possible amount in the coatings.
MilliQ water was diluted in the same way as a control. The suspensions (200 µL) were added to the
precultured cells. After 24 h, the cellular membrane damage was determined by detecting the amount
of lactate dehydrogenase (LDH) which had leaked the inside of the cells. The cell culture supernatant
(100 µL) was mixed with 100 µL of staining solution (Cytotoxicity Detection Kit, 11644793001, Roche,
Basel, Switzerland) and incubated for 10 min in the darkness. The reaction was stopped with 50 µL
of 1 M HCl. Absorbance was measured with a multiplate reader (Infinite F200, Tecan Group Ltd.,
Männedorf, Switzerland) at 490 nm (reference 690 nm). For analysis of the metabolic activity, 20 µL of
the CellTiter-Blue® Reagent (CellTiter-Blue®Cell Viability Assay, G8081; Promega, Madison, WI, USA)
was added to the cultured cells (100 µL). After 4 h incubation at 37 ◦C in a 5% CO2, 95% humidified air
atmosphere fluorescence (540 Ex/595 Em) was detected with a multiplate reader (Infinite F200).
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2.14. Cell Adhesion and Proliferation
As described previously, a modified LDH activity assay was used to evaluate the HGFIB adhesion
and proliferation on the nanoparticle coatings in comparison to uncoated titanium, according to
Heuer et al. [33]. Briefly, for the adhesion/proliferation testing, the coated and uncoated titanium
discs were placed in 24-well cell culture plates and were covered with human gingival fibroblasts at
a density of 1.5 × 104 cells/mL/well. After an incubation period of 24 h or 72 h, the samples were
washed with Hanks’ Balanced Salt solution (HBSS) to remove unattached cells. The adherent cells
were lysed using 10% Triton-x-100 (93416, Sigma-Aldrich Chemie GmbH, Steinheim, Germany) at
37 ◦C for 30 min. The released lactate dehydrogenase was measured with the Cytotoxicity Detection
Kit. The number of adherent fibroblasts was calculated through comparison with a corresponding
standard curve. The statistical evaluation of the cell adhesion and proliferation were performed using
GraphPad Prism 7 (GraphPad Software, La Jolla, CA, USA). A Kruskal–Wallis test was used to analyze
the statistical differences between the uncoated and coated titanium. Differences were considered
statistically significant at p < 0.05.
2.15. Cell Morphology
Titanium samples were rinsed with PBS (L1825, Biochrom AG) and fixed for 4 h in 0.1%
glutaraldehyde and 4% paraformaldehyde diluted in 200 mM HEPES buffer (4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid from Sigma Aldrich). Afterwards, the samples were dehydrated in
graded ethanol solutions before being dried completely through critical point drying. Samples for
scanning electron microscopy (SEM) were mounted on stubs, sputtering coated (POLARON Sputter
Coater SC7500, Ringmer, UK) with a thin layer of gold and measured in a SEM 505 (Philips, Eindhoven,
The Netherlands) at 10 kV.
3. Results and Discussion
3.1. Ionotropic Gelation
Alg/peptide nanoparticles were obtained via ionotropic gelation, which spontaneously occurs
upon combination of aqueous solutions of oppositely charged polyions [26,34]. Solutions of purified
sodium alginate and the peptides PLL and KKKK-GRD-ARGSV↓NITEGE-DRG-KKKK (further
denoted as NITEGE) were used. Depending on the concentration of the components, we were
able to obtain narrowly distributed particles in terms of particle size and zeta potential. The particle
formation process was carried out in MilliQ water with 1 mg/mL concentrations of sodium alginate
and the peptides each. The corresponding particle size distributions and zeta potential curves are
presented in Figure 1. For Alg/PLL, a 4:1 ratio was used, and particles with a size in the range of
330 ± 35 nm and a polydispersity index (PDI) of 0.23 were obtained. The particles had a negative zeta
potential of −48 ± 1 mV. However, for the Alg/NITEGE particles, a 1:1 ratio was chosen, leading to an
extremely narrow distributed particle size of 143 ± 25 nm and a PDI of 0.15. The zeta potential was
found to be −40 ± 1 mV.
Properties like the stability of the nanoparticles or the strength of interaction between the
nanoparticles and the surfaces can be estimated from the zeta potential. According to Pujala, sufficient
stability of colloidal systems is given at zeta potentials of −30 mV or lower, since coagulation is
prevented by the electrostatic repulsion of the particles [35]. Slight changes in the ratio between alginate
and the corresponding peptide result in broader distributions of particle sizes and zeta potentials.
Since the smaller amount of anionic alginate was added into the formulation of Alg/NITEGE compared
to Alg/PLL, the zeta potential of the latter was slightly less negative. However, the difference was
lower than expected, probably because of the number of lysine groups, which is reduced by 20% in
NITEGE compared to the PLL sequence. Moreover, the presence of anionic amino acids like glutamic
acid (E) and aspartic acid (D) further compensates positive charges in the NITEGE peptide.
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Figure 1. (A) Particle size distributions and (B) zeta potential curves of alginate/α-poly-L-lysine
(Alg/PLL) and alginate/KKKK-GRD-ARGSV↓NITEGE-DRG-KKKK (Alg/NITEGE) nanoparticles in
MilliQ, obtained through dynamic light scattering (DLS).
To investigate particles further, NTA was used, which is a technique of following the Brownian
motion of single particles by means of light microscopy. With aid of the Stokes–Einstein relation,
the hydrodynamic diameter for each of the tracked particles can be determined. The data obtained
for the two Alg/peptide systems are displayed in Figure 2. The NTA measurements resulted in
particle sizes of about 211 ± 6 nm for the Alg/PLL system and 83 ± 2 nm for the Alg/NITEGE
system, which were somewhat smaller compared to the DLS investigations. This discrepancy can
be ascribed to the different evaluation methods of these characterization techniques. Nanoparticle
tracking analysis is based on number-weighted size distributions, whereas the primary result of the
DLS are intensity-weighted data. Upon conversion of the intensity-weighted size distributions obtained
through DLS into number-weighted size distributions, we could elicit hydrodynamic diameters of
208 ± 6 nm for Alg/PLL and 70 ± 15 nm for Alg/NITEGE, respectively. These particle sizes then can
be directly correlated to the results obtained from NTA investigations.
3.2. Particle Degradation
The degradation of the Alg/peptide nanoparticles in the presence of infection-related proteases
is important for the application as a smart drug delivery system. Preliminary investigations with
commercially available enzymes were carried out in vitro and monitored via Dynamic Light Scattering.
For this purpose, three enzymes were chosen, namely, trypsin, thermolysin, and alginate-lyase.
The peptidase trypsin is a mixture of three digestion enzymes cleaving proteins in the gut [36].
It was selected due to its ability to cleave a protein sequence after a lysine residue, as they are present
in both the PLL and the NITEGE sequence [37]. Thermolysin is a thermostable enzyme belonging
to the family of metallopeptidases. Thermolysin is able to degrade peptide bonds after large and
hydrophobic amino acids like leucine, isoleucine, and phenylalanine [38]. Thus, it is not capable
to degrade poly-L-lysine, whereas the NITEGE should be hydrolyzed. The effect of the alginate
degradation of the particles was investigated through the addition of alginate-lyase. It is an enzyme
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well known for the cleavage of the glycosidic bond through a β-elimination reaction, generating much
smaller molecules, like 4-deoxy-l-erythro-hex-4-enepyranosyluronate [39].Bio olecules 2018, 8, x 8 of 21 
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Figure 2. Nanoparticle tracking analysis (NTA) curves for (A) Alg/PLL and (B) Alg/NITEGE
nanoparticles. The particles were prepared according to the standard procedure before the dispersions
were diluted by 1:10. Depicted are five different measurements to show the reproducibility.
As shown in Figure 3A, for the Alg/PLL system, no significant change of particle size could be
observed in the presence of thermolysin and in the MilliQ water control solution within three days.
By contrast, incubation with trypsin led to a decreasing particle size, as expected for a degradation
process. The main decrease in particle size took place during the first 20 h. Subsequently, a slower
decrease was observed. The particle size was reduced to 50% of their original size. Addition of the
lyase, which is capable of cleaving the alginate, induced a particle size increase in the first 4 h and a
significant drop afterwards. This behavior is mainly attributed to the aggregation of cleaved alginate
residues after the enzymatic reaction. When the particles become too large, a subsequent sedimentation
process can be observed, leading to a white precipitate in the cuvette. Thus, the supernatant again
exhibits smaller particles to be detected.
The degradation of the Alg/NITEGE system, displayed in Figure 3B, again indicated stable
nanoparticles in MilliQ water at 37 ◦C up to 3 days. Upon addition of trypsin, thermolysin,
and alginate-lyase, the particle sizes initially increased for all formulations but to a different extent.
The increase in particle size was most prominent for trypsin, as the particles grew to 300% of their
original size after 4 h. By contrast, the particle size in the presence of thermolysin and alginate-lyase
increased much more slowly, reaching similar size values not before 20 h of incubation time. Unlike
trypsin and thermolysin, the addition of alginate-lyase led to a constant rise in particle size with
no initial increase in the very first hours. The fact of increasing particle sizes after the addition of
enzymes let us surmise that small fragments of the peptides (for trypsin and thermolysin) or alginate
(for alginate-lyase) may have been cleaved and reintegrated in the particles. Another explanation is
Biomolecules 2018, 8, 103 9 of 20
related to particle swelling processes that were reported by McDonald et al. and Thornton et al. as
consequences of enzymatic reactions [40,41]. They proposed a particle size increase due to electrostatic
repulsion between protonated lysine residues in the peptide sequence and amino groups that form
upon cleavage. Nonetheless, a change in particle size upon addition of enzymes indicates that the
particles are not stable anymore but will be altered by the proteases in a degradation-like manner.
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Figure 3. Degradation studies for (A) Alg/PLL and (B) Alg/NITEGE nanoparticles in MilliQ water
(filled triangles) at 37 ◦C. After formation, the particles were coincubated with enzyme solutions (each
2.5 µg/mL) of thermolysin, trypsin, and alginate-lyase for up to 80 h. The particle size was monitored
over the incubation time through DLS.
Since the Alg/NITEGE nanoparticles were designed to be cleaved by aggrecanase, the influence
of this infection-related protease was also investigated. When aggrecanase was added, again, a distinct
increase in particle size could be observed, as had been already shown for trypsin and thermolysin,
whereas Alg/PLL nanoparticles did not show any change in particle size over 50 h incubation time
(data not shown).
3.3. Encapsulation of IFN-β
Interferon-β was selected as a model protein. It is an antiviral and antitumoral protein secreted as
an immune answer to viral infections like hepatitis or cancer diseases [42]. To determine encapsulation
efficiency, a series of known IFN-β concentrations in MilliQ water was prepared and measured by a
bioluminescence assay to obtain calibration curve. We encapsulated 5000 U/mL IFN-β in Alg/NITEGE
particles through ionic gelation in the presence of the INF-β. The suspension was centrifuged at 16,800
rpm for 15 min. The IFN-β concentration in the supernatant was determined by the bioluminescence
assay. The encapsulation efficiency was calculated using the following equation.
ee [%] =
measured RLU (particles + IFNβ)
measured RLU ( f ree IFNβ)
× 100
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We could obtain a minimal encapsulation efficiency of about 25 ± 6%. This is significantly lower
than the encapsulation efficiency obtained for the growth factor bone morphogenetic protein 2 (BMP-2)
in a chitosan/tripolyphosphosphat nanohydrogel (>90%) [30]. The difference can be explained by the
complicated interplay of electrostatic and other entropic forces, mediated by van der Waals interactions
and hydrogen bonding, which have to be taken into account to understand the binding and release
between polymeric carrier and protein [43].
3.4. Coating of Titanium Substrates
Titanium and its alloys are among the most popular materials used as orthopedic and dental
implants, due to their good mechanical and chemical properties, as well as their biocompatibility [44,45].
Therefore, Ti-6Al-4V alloy plates were used for the coating procedure. The zeta potential of the
Alg/peptide nanoparticles was found to be negative (see above). However, the surface charge of
titanium has been determined by Kamada et al. to be also negative, with a zeta potential of−25 mV [46].
To facilitate layer-by-layer deposition of the Alg/peptide nanoparticles, adsorption of cationic PEI as
a base layer is well established, as it results in a charge reversal of the surface [47]. This base layer
was installed by immersion of titanium substrates in an aqueous PEI solution (5% w/w). Onto this
base layer, the Alg/peptide suspension was spray-coated. The characterization of the coatings was
performed by means of ellipsometry, providing information about the layer thickness, RAIRS, and XPS.
3.5. Ellipsometry
The ellipsometric thickness of the PEI-base layer was determined to 3–6 nm with only small
deviations. Subsequently, the Alg/peptide dispersions were spray-coated onto the PEI layer for a
defined period of time to deposit approximately 20 µL of the nanoparticle dispersion. After a rinsing
step, Alg/PLL coatings exhibited film thicknesses in the range of 80 ± 5 nm, while Alg/NITEGE gave
lower thicknesses, around 54 ± 6 nm. In contrast to DLS, where hydrodynamic particle sizes were
measured, ellipsometry was performed in a dry state. Due to the loss of water, the layer thickness
was not expected to be identical to the particle size obtained from DLS measurements. Furthermore,
a rearrangement of nanoparticles into homogenous film took place [48]. Aggregation and coalescence
of polymer particles from a suspension by evaporation of the solvent is a well-known phenomenon for
water-borne paints [49].
Nevertheless, the difference between the hydrodynamic radii for the Alg/peptide nanoparticle
could also be found in the layer thicknesses determined by ellipsometry. Additionally, the different zeta
potential could have an impact on the layer thicknesses of the Alg/peptide coatings. As mentioned
before, the zeta potential is a characteristic feature that describes the stability of the particles, as well
as the interaction with the substrate surface. The difference between −48 mV for the Alg/PLL
nanoparticles compared to −40 mV for the Alg/NITEGE system is assumed to be caused by the
different charge density along the peptide chains. This will also influence the adhesion of the layers on
the substrate material. Therefore, Alg/NITEGE coatings, which exhibited a less negative zeta potential,
could be partially removed from the substrate surface by rinsing with water.
3.6. Characterization of the Coating by Reflection-Absorption Infrared Spectroscopy
We further characterized the layers through RAIRS. In addition to the nanoparticles,
both components were coated separately onto titanium substrates and analyzed by RAIRS. In Figure S1
(see Supplementary Material), the relevant wave number range from 2050–900 cm–1, which was used
to evaluate the deposition of the Alg/peptide particles, is depicted. The PLL spectrum in A showed
significant bands, around 1671 cm–1 and 1547 cm–1, which could be assigned to amide I and amide
II bending vibrations [50]. Sodium alginate showed important absorption bands at 1623 cm–1 and
1419 cm–1, attributed to asymmetric and symmetric stretching vibrations of the carboxylate salt ion,
respectively. The band at 1097 cm–1 arises from stretching vibrations of the hydroxyl groups present in
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alginate [51]. In the spectrum of the coated Alg/PLL nanoparticles, all bands aforementioned were
detected, suggesting the successful deposition of the nanoparticles on titanium substrates.
Investigations of Alg/NITEGE layers were performed in the same way. The aggrecanase-labile
peptide sequence showed distinct bands at 1684 cm–1 and 1551 cm–1, attributed to the amide I and II
bending vibrations, similar to PLL. Further peaks at 1206 cm–1 and 1135 cm–1 were detected, probably
belonging to O-C stretching vibrations from the aspartic acid residues present in the NITEGE sequence.
Together with the bands of alginate spectrum, we could again confirm the immobilization of the
Alg/NITEGE particles on titanium substrates.
3.7. X-ray Photoelectron Spectroscopy Measurements
The coated substrates were characterized by means of XPS measurements to elucidate the
elemental composition of the surface probing the top 10 nm of the film. As can be seen in Figure 4,
uncoated titanium samples were compared to the samples coated with Alg/PLL and Alg/NITEGE
nanoparticles. For the uncoated surface, high amounts of oxygen (54%) and titanium (18%) could be
found, attributed to the passivating titanium oxide layer. The detection of aluminum (2%) was related
to the Ti-6Al-4V alloy that was used as substrate material. Additionally, carbon (23%) was detected,
which results from common impurities for samples handled in air. By contrast, both Alg/peptide
nanoparticle coated samples exhibited no titanium signal, indicating complete coverage of the surfaces
with layers > 10 nm. Furthermore, oxygen (26%) was decreased, whilst carbon (62%) and nitrogen
(between 9% and 12%) showed a significant increase.
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uncoated Ti-6Al-4V alloy substrate showed the atomic concentration on the surface in percent. 
Figure 4. X-ray photoelectron measurement of Alg/peptide coated Ti-6Al-4V substrates and an
uncoated Ti-6Al-4V alloy substrate showed the atomic concentration on the surface in percent.
Substrates were immersed in polyethyleneimine (PEI) (5% w/w in MilliQ) before Alg/PLL (each
1 mg/mL in MilliQ, volume ratio 4:1), and Alg/NITEGE (each 1 mg/mL, volume ratio 1:1) nanoparticle
suspensions were spray-coated onto the surfaces.
The atomic concentrations obtained through XPS are in good agreement with the theoretically
calculated composition given in Table 1. Thus, the immobilization of Alg/peptide nanoparticles on the
titanium surface could be clearly confirmed.
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Table 1. Theoretically calculated and by means of X-ray photoelectron spectroscopy (XPS)
experimentally determined atomic concentrations of oxygen (O), carbon (C), and nitrogen (N) of
the Alg/peptide nanoparticle coatings (each 1 mg/mL in MilliQ, for Alg/PLL volume ratio 4:1 and
for Alg/NITEGE volume ratio 1:1). The content of hydrogen was not considered in the calculations.
The carbon/nitrogen ratio (C/N ratio) is reported in addition.
Alg/PLL Alg/NITEGE
Theoretically Experimentally Theoretically Experimentally
Oxygen (O) 33% 27% 28% 25%
Carbon (C) 47% 63% 53% 61%
Nitrogen (N) 5% 9% 12% 12%
C/N-ratio 9.4 7 4.4 5.1
3.8. Degradation Behavior (Ellipsometry)
Degradation studies were carried out with substrates, which were coated as described above.
In order to evaluate degradation, substrates were incubated at 37 ◦C in the corresponding enzyme
solutions (trypsin, thermolysin, and alginate-lyase with 2.5 µg/mL each) and were investigated by
means of ellipsometry with regard to layer thickness in the dry state after defined incubation periods.
For the Alg/PLL coatings, as can be seen in Figure 5A, the incubation in MilliQ water as control
had no significant effect on the layer thickness of about 80 nm in the respective period. A comparable
result was obtained for incubation with thermolysin, indicating stability of the coating against this
enzyme. However, a significant decrease in layer thickness was observed when the layer was incubated
with trypsin or Alg-lyase. The layers incubated in trypsin solution showed a distinct decrease in
layer thickness of 15 nm after the first 5 h, with no further change within the next 122 h. Interestingly,
alginate-lyase induced a much stronger degradation in the first 5 h, leading to final thicknesses of
about 20 nm.
Similar results could be obtained for the Alg/NITEGE coatings. However, a slightly poorer
stability in MilliQ water was observed, as the layer thickness was slowly declining from 60 nm to
40 nm over a period of 67 h. This behavior is probably ascribed to a lower stability of the film, because
of the smaller number of lysine groups in the peptide compared to the PLL. Compared to MilliQ
conditions, we could observe a more serious degradation of the coatings when incubated in the
presence of trypsin and thermolysin. Between these two enzymes, the extent of degradation was more
pronounced for trypsin, presumably attributed to the higher number of cleaving sites in the NITEGE
peptide. The incubation in alginate-lyase again showed a dramatic decrease after short periods, with no
further degradation up to 67 h. Thus, both nanoparticle systems showed sufficient stability in water at
37 ◦C but got rapidly degraded in the presence of enzymes that can either cleave the peptide crosslinker
or the alginate itself. The differences in the layer thickness decrease between thermolysin, trypsin,
and alginate-lyase, which could probably be explained by the different cleavage mechanism.
We suppose the enzymatic reaction leading to the degradation of alginate to be more significant,
as can be seen in the decline in layer thickness. Large fragments were degraded in the very first hours
and were subsequently removed from the substrates’ surfaces. This process led to the major decrease
in layer thickness. After a certain period, the reaction slowed down considerably, because less alginate
was present on the substrate.
By contrast, the degradation of the peptide sequences (PLL and NITEGE) seems to play a less
prominent part, as the layer thickness only decreased in the range of 15 to 20 nm. While degrading
the peptide linker, the alginate remains unaffected and is probably bound to the cationic surface by
electrostatic interactions. This process may lead to the masking of the surface by alginate, which cannot
be degraded by trypsin or thermolysin. We also observed an influence of the enzyme concentration,
where, at a higher enzyme concentration of 50 µg/mL, thickness decrease is more pronounced (see
Figure S2, Supplementary Material). Despite all differences, the results clearly indicated that the layers
were attached to the titanium substrate and were at least partially degraded by enzymes.
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Figure 5. Monitoring ellipsometric layer thicknesses of (A) Alg/PLL and (B) Alg/NITEGE coatings 
while coincubated with control, thermolysin, trypsin, and alginate-lyase (each 2.5 µg/mL). n = 3. 
We suppose the enzymatic reaction leading to the degradation of alginate to be more significant, 
as can be seen in the decline in layer thickness. Large fragments were degraded in the very first hours 
and were subsequently removed from the substrates’ surfaces. This process led to the major decrease 
in layer thickness. After a certain period, the reaction slowed down considerably, because less 
alginate was present on the substrate. 
By contrast, the degradation of the peptide sequences (PLL and NITEGE) seems to play a less 
prominent part, as the layer thickness only decreased in the range of 15 to 20 nm. While degrading 
the peptide linker, the alginate remains unaffected and is probably bound to the cationic surface by 
electrostatic interactions. This process may lead to the masking of the surface by alginate, which 
cannot be degraded by trypsin or thermolysin. We also observed an influence of the enzyme 
concentration, where, at a higher enzyme concentration of 50 µg/mL, thickness decrease is more 
pronounced (see Figure S2, Supplementary Material). Despite all differences, the results clearly 
indicated that the layers were attached to the titanium substrate and were at least partially degraded 
by enzymes. 
3.9. Stability of Deposited IFN--Loaded Alg/NITEGE Nanoparticles 
Aggrecanase-labile IFN--loaded Alg/NITEGE nanoparticles (Alg/IFN-/NITEGE) were 
deposited onto polished titanium substrates to investigate the release kinetics of the protein. The 
coated samples were incubated in cell culture media with and without FCS, as well as in PBS. After 
different times of incubation (30 min, 2 h, and 24 h), the media were removed and the IFN- 
concentration was measured using a luciferase assay. Figure 6 shows the fold induction values for 
each incubation medium after three time points (30 min, 2 h, and 24 h). The fold induction is the 
bioluminescence intensity measured for the sample divided by the basal intensity that the MX2Luc2 
cells exhibit without induction by IFN-. A fold induction value of 1 indicates that no IFN- was 
released. This could be clearly seen for the incubation in PBS, even after 24 h. However, when 
incubated in a cell culture medium, irrespective of FCS addition, the fold induction values were 
Figure 5. onitoring ellipso etric layer thicknesses of ( ) Alg/PLL and ( ) lg/ ITE E coatings
hile coincubated ith control, ther olysin, trypsin, and alginate-lyase (each 2.5 µg/ L). n = 3.
3.9. Stability of Deposited IFN-β-Loaded Alg/NITEGE Nanoparticles
Aggr canase-labile IFN-β-loaded Alg/NITEGE nanoparticles (Alg/IFN-β/NITEGE) were
deposited onto polished titanium substrate to investigate the release kinetic of the protein. Th oated
sampl s were incubated in cell culture me ia with nd with ut FCS, as well as in PBS. After differ nt
times of incubatio (30 min, 2 h, nd 24 h), the media were removed and the IFN-β concentration
was measured using a luciferase assay. Figure 6 shows the fold induction value for each incubation
medium after three time points (30 min, 2 h, and 24 h). The fold inducti n is the bioluminescence
intensity measured for the sampl divided by the bas l intensity that the MX2Luc2 cells exhibit without
induction by IFN-β. A fold induction value of 1 indicates that n IFN-β w s released. This could
be clearly se n for the incubation in PBS, even after 24 h. However, when c bated in a cell culture
medium, irrespectiv of FCS addition, the fold inducti values were significantly higher indicating
that IFN-β was released. This release might be due to high salt concent ations in DMEM, causing
reorganization processes. It is likely that multiv lent cations present in DMEM can compete with the
NITEGE peptide sequence for the interaction with the alginate. Therefore, an ion exchange would
take place that can result in the release of IFN-β. Such a dynamic behavior has been observed for
alginate gels by I nita et al. [52]. Furthermore, a shar drop could be observed in fold induction
between 30 min and 24 h, although there is no media change step. This decrease can be explained by
the normal loss of activity of IFN-β when stored in solution. Nevertheless, deposited IFN-β-loaded
nanoparticles seemed to be sufficiently stable in PBS, whereas a release in cell culture media must be
taken into account.
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Figure 6. Fold induction values of deposited IFN--loaded Alg/NITEGE nanoparticles after 
coincubation with cell culture medium (DMEM) with and without fetal calf serum (FCS) and 
phosphate buffered saline (PBS), as reference calculated at three time points. 
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Both a CellTiterBlue assay and a LDH assay were carried out, in order to rule out cytotoxicity of the 
nanoparticle dispersions. The fluorometric CellTiterBlue assay is based on the ability of living cells 
to reduce the redox dye resazurin into the fluorescent product resorufin [54]. Human gingival 
fibroblasts were treated with different concentrations of either the nanoparticle formulations or 
MilliQ water as control for 24 h. The evaluation of the metabolic activity using CellTiterBlue reagent 
presented in Figure 7 showed high cell viabilities above 100% independently from the concentration. 
Thus, there was no negative effect on the metabolic activity of the fibroblasts. 
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coincubation with cell culture medium (DMEM) with and without fetal calf serum (FCS) and phosphate
buffered saline (PBS), as reference calculated at three time points.
3.10. Cell studies—Cytocompatibility of Nanoparticle Suspensions
The cytocompatibility of the Alg/peptides was studied with HGFIB. Fibroblasts are the most
important cell type of soft tissue and are crucial for the wound closure around dental implants [53].
Both a CellTiterBlue assay and a LDH assay were carried out, in order to rule out cytotoxicity of the
nanoparticle dispersions. The fluorometric CellTiterBlue assay is based on the ability of living cells to
reduce the redox dye resazurin into the fluorescent product resorufin [54]. Human gingival fibroblasts
were treated with different concentrations of either the nanoparticle formulations or MilliQ water
as control for 24 h. The evaluation of the metabolic activity using CellTiterBlue reagent presented
in Figure 7 showed high cell viabilities above 100% independently from the concentration. Thus,
there was no negative effect on the metabolic activity of the fibroblasts.
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Additionally, a colorimetric LDH assay was performed to quantify LDH, which is released in
medium by cellular membrane damage, serving as a biomarker for cytotoxicity and cytolysis [54].
Different concentrations of nanoparticle suspensions and MilliQ water as control were tested in
combination with human gingival fibroblasts. As shown in Figure 8, no cytotoxic effect was detected
over the entire concentration area. Furthermore, in comparison to the MilliQ control, there was only
little difference in the percentage of cellular membrane damage for the nanoparticle suspensions.
CellTiterBlue as well as LDH assay indicated the nanoparticle suspensions’ excellent cytocompatibility.
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Figure 8. Membrane damage of HGFIB in response to Alg/PLL and Alg/NITEGE nanoparticle
suspensions after 24 h. Alg/PLL and Alg/NITEGE nanoparticles and MilliQ water as control were
diluted in DMEM with 5% FCS. Untreated cells were set to 0% of membrane damage. Mean and
standard deviation of three independent experiments are shown.
3.11. Cell Studies—Cell Adhesion/Proliferation on Coated Samples
A modified LDH activity assay was used to investigate the cell adhesion and proliferation of the
corresponding coated substrates in comparison to uncoated titanium. In this experiment, the number
of cells adherent on the surface was determined by the LDH test after intentional lysis of the cells [33].
In literature, solutions of PEI have been reported to be cytotoxic [47,55]. However, the!3–6 nm thick
PEI layer was not expected to have an influence on the cytocompatibility of the coatings, since it was
fully covered with the Alg/peptide nanoparticle layer. Both the Alg/peptide coatings and the PEI
base layer were examined for cell adhesion. After 24 h incubation, the number of adherent cells was
counted, being a measure of the initial cell adhesion. The cell adhesion only on Alg/PLL coating
was significantly decreased compared to uncoated Ti-6Al-4V (Figure 9). The cell adhesion on the
Alg/NITEGE and PEI coating was similar to the control. After 72 h incubation, the proliferation
of the cells on the surfaces could be evaluated. All three coatings exhibited a significant decrease
of adherent cells in the region of 15% to 45% compared to the uncoated Ti-6Al-4V. That means the
investigated coated surfaces showed cell-repellent properties, because the adhesion and proliferation of
the fibroblast cells were reduced. This behavior is well known for pure alginate coatings and is mainly
attributed to high hydrophilicity, in addition to the negative charge of the alginate (in Alg/peptide
formulations), discouraging protein adsorption and cell attachment [56,57].
Scanning electron microscopy images (Figure 10) further confirm these findings. The human
gingival fibroblasts showed normal fibroblast morphology and a high proliferation on the uncoated
titanium. In contrast, the fibroblast morphology on the Alg/peptide coatings was rounded. On the
Alg/PLL coated titanium, only a few rounded cells can be found after 24 and 72 h. The fibroblasts on
the Alg/NITEGE coating showed a small spread-out morphology. This rounded morphology indicates
a weak surface–cell interaction. The results are in good accordance to the results of the cell adhesion
tests (see Figure 9).
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In order to overcome the weak adhesion and proliferation of the fibroblasts on the coated surfaces,
RGD-modified alginates could be used. The tripeptide RGD, consisting of arginine (R), glycine
(G), and aspartic acid (D), is known to promote cell adhesion, since it is a common motive in cells,
allowing the binding of surface receptors, like integrins. Preliminary experiments were carried out
with RGD-Alginate in combination with the cleavable sequences PLL and NITEGE, which showed a
significant improvement of the fibroblast adhesion on the surfaces (Figures S3–S6).
4. Conclusions
We have demonstrated that well-defined nanoparticles can be formed via ionotropic gelation
of commercially available alginate with cationic peptides. As peptides, poly-l-lysine or an
aggrecanase-labile lysine rich sequence (KKKK-GRD-ARGSV↓NITEGE-DRG-KKKK) were used.
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The nanoparticle dispersions could be used to spray-coat titanium samples, for example, implants,
and form homogenous films with less than 80 nm layer thickness. The film formation could be clearly
verified by means of ellipsometry, RAIRS, and XPS measurements. Degradation experiments were
performed for the dispersed nanoparticles in solution and for deposited layers, showing a sufficient
stability in control media and a desired degradation when coincubated with enzymes. Thus, a specific
and tunable degradation of the hydrogel network forming the particles in water and the films on the
titanium surface was established. The nanoparticle dispersion and films did not show any cytotoxicity
towards human gingival fibroblasts. However, the coatings showed weak cell adhesion and almost
no cell proliferation. This is a general challenge associated with very hydrophilic alginate hydrogels
and could be overcome by binding short RGD peptide sequences to the alginate. Encapsulation of the
antiviral agent IFN-β could be realized with moderate efficiency of approximately 25%. The loaded
Alg/NITEGE particles also formed thin coatings on titanium. However, in cell culture media, these
coatings show limited stability, resulting in a very fast IFN-β-release. A stabilization of the hydrogel
network against dynamic cation exchange is necessary.
Supplementary Materials: The following are available online at http://www.mdpi.com/2218-273X/8/4/103/s1,
Figure S1: Reflection absorption infrared spectra (RAIRS) of (A) titanium coated with PLL, alginate, and the
nanoparticle system Alg/PLL and (B) titanium coated with NITEGE, alginate, and the nanoparticle system
Alg/NITEGE. The relevant wave number range from 2050– 900 cm–1 is presented, Figure S2: Monitoring
ellipsometric layer thicknesses of (A) Alg/PLL and (B) Alg/NITEGE↓ARGSV coatings while coincubated
with a higher concentration of 50 µg/mL of thermolysin, trypsin, and alginate-lyase. (N = 3)., Figure S3:
Metabolic activity of HGFIB in response to RGD-Alg/PLL and RGD-Alg/NITEGE nanoparticle suspensions
after 24 h. RGD-Alg/PLL and RGD-Alg/NITEGE nanoparticles and MilliQ water as control were diluted in
DMEM with 5% FCS. Untreated cells were set to 100% metabolic activity. Mean and standard deviation of three
independent experiments are shown, Figure S4: Membrane damage of HGFIB in response to RGD-Alg/PLL and
RGD-Alg/NITEGE nanoparticle suspensions after 24 h. RGD-Alg/PLL and RGD-Alg/NITEGE nanoparticles
and MilliQ water as control were diluted in DMEM with 5% FCS. Untreated cells were set to 0% of membrane
damage. Mean and standard deviation of three independent experiments are shown, Figure S5: Quantification
of adherent HGFIBs on RGD-Alg/PLL and RGD-Alg/NITEGE coatings and uncoated Ti-6Al-4V substrate after
24 and 72 h. The data were related to uncoated Ti-6Al-4V after 24 and 72 h, which were set to 100%. Mean and
standard deviation of three independent experiments are shown. The statistical significance was determined using
the Kruskal–Wallis test, with p = 0.05. # indicates statistical significance (p < 0.05) compared to Ti-6Al-4V, 72 h,
Figure S6: SEM images of HGFIBs cultured on uncoated Ti-6Al-4V (A and D), RGD-Alg/PLL coated Ti-6Al-4V
(B and E), and RGD-Alg/NITEGE coated Ti-6Al-4V (C and F) after 24 h (A, B and C) and 72 h (D, E and F).
Scale bar = 200 µm.
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